FDA Inspection 1134140 — Andrew Blauvelt, MD, MBA
The FDA completed an inspection of Andrew Blauvelt, MD, MBA on Dec 8, 2020 in Portland, OR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 8, 2020
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Portland, OR (United States)
Additional details
Clinical Investigator (CI)